A method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses

Details for Australian Patent Application No. 2012227337 (hide)

Owner Keio University Daiichi Sankyo Company, Limited

Inventors Fukuda, Keiichi; Hattori, Fumiyuki

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2012227337

Parent 2007210580

Filing date 21 September 2012

Wipo publication date 18 October 2012

International Classifications

C12N 5/00 Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 5/077 Undifferentiated human, animal or plant cells, e.g. cell lines - Mesenchymal cells, e.g. bone cells, cartilage cells, marrow stromal cells, fat cells or muscle cells

Event Publications

11 October 2012 Complete Application Filed

18 October 2012 Application Open to Public Inspection

  Published as AU-A-2012227337

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012227338-In-vivo calibration of contact force-sensing catheters using auto zero zones

2012227336-Self-centering, anti-seizing acetabular liner